Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Diabetic Neuropathy in Type 1 Diabetes
NCT02138045Completed
- Sponsor
- Aalborg University Hospital
- Start
- May 2014
- Primary completion
- Feb 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in diabetic neuropathy comparing Placebo with Liraglutide (2 arms). Primary endpoints: RIII withdrawal reflex activity at 6 months and Evoked brain potentials at 6 months. Started May 2014; status: completed.
02
Drugs
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT02138045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138045.